Abstract
Continuous low-level (0.825 mg/kg/h for 20 h) administration of AP through SC in-dwelling silicone reservoirs in the rat induced behavioral and biochemical changes that were similar to those induced by low levels (0.1 mg/kg) of acutely administered AP (decreased behavioral activity and decreased dopamine metabolism in the striatum). With longer periods of continuous AP exposure (40 h or more) the activity-depressing effects of low-level AP diminished. Concurrently a novel behavioral syndrome emerged characterized by limb flicks, body shakes, sudden orienting responses, and motor abnormalities, such as tremors of the jaw muscles, chewing movements, prominent tongue extensions, and body ‘tics’. This behavioral syndrome became more apparent following cessation of drug treatment. These novel behavioral changes, which were accompanied by increased behavioral responsiveness to acutely administered AP and amphetamine, were correlated with increased levels of dopamine, homovanillic acid, and 3,4-dihydroxyphenylacetic acid in the striatum but not the nucleus accumbens. This novel behavioral syndrome appears to reflect a rebound increase in dopaminergic mechanisms in striatum following their chronic suppression by low levels of AP.
Similar content being viewed by others
References
Aghajanian GK, Bunney BS (1975) Dopaminergic and nondopaminergic responses to putative transmitters. In: Boissier JR, Hippius H, Pichot D (eds) Neuropsychopharmacology. Elsevier, Amsterdam, pp 444–452
Andén EE, Rubenson A, Fuxe K, Hokfelt T (1967) Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol 19:627–629
Angrist B, Sathanathan G, Gershon S (1973) Behavioral effects of l-dopa in schizophrenic patients. Psychopharmacology 31:1–12
Angrist B, Sathanathan G, Wilk S, Gershon S (1974) Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 11:13
Angrist B, Rotogen J, Gershon S (1980) Response to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects. Psychopharmacology 67:31–38
Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney BS (eds) Pre- and postsynaptic receptors. Dekker, New York, p 49
Corsini GU, Del Zompo M, Cinachetti L, Mangoni A, Gessa GL (1977) Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man. Adv Biochem Psychopharmacol 16:645–648
Creese I, Iversen S (1973) Blockade of amphetamine-induced motor stimulation in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 55:369–382
Creese I, Burt DR, Synder S (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antipsychotic drugs. Science 192:481–483
Davis JM, Jankowsky DS (1974) Amphetamine and methylphenidate psychosis. In: Usdin E, Synder S (eds) Frontiers in catecholamine research. Pergamon, Oxford, pp 977–987
DiChiara G, Porceddu ML, Vargu L, Argiolas A, Gessa G (1976) Evidence for dopamine receptors mediating sedation in the mouse. Nature 244:564
Ellinwood EH, Escalante O (1970) Behavioral and histopathological findings during chronic methedrine intoxication. Biol Psychiatry 2:27–35
Ellinwood EH, Kilbey MM (1977) Chronic stimulant intoxication models of psychosis. In: Hanin I, Usdin E (eds) Animals models in psychiatry and neurology. Pergamon, Oxford, pp 61–74
Ellison G, Morris W (1981) Opposed stages of continuous amphetamine administration. Parallel alterations in motor stereotypes and in vivo spiroperidol. Eur J Pharmacol 74:207–214
Ellison G, Ratan R (1982) The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism. Life Sci 31:771–778
Ellison G, Eison M, Huberman H (1978) Stages of amphetamine intoxication: Delayed appearance of paranoid-like behaviors in rat colonies. Psychopharmacology 56:293–299
Ellison G, Eison M, Huberman H, Daniel F (1979) Long-term changes in copaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201:276–278
Ellison G, Neilson E, Lyon M (1981) Animal models of psychosis: Hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication. J Psychiatr Res 16:13–22
Grabowska M (1976) The involvement of serotonin in the mechanism of central action of apomorphine. Pol J Pharmacol 28:389–394
Griffith J, Cavanaugh J, Held N, Oates J (1972) d-Amphetamine: Evaluation of psychomotor properties in man. Arch Gen Psychiatry 26:97–100
Janowsky DS, El-Yousef MK, Davis JM (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 28:185–190
Kehr W, Carlsson A, Lindquist M (1975) Biochemical aspects of dopamine agonists. In: Calne D, Chase TN, Barbeau A (eds) Dopamine mechanisms. Raven, New York, pp 185–196
Melzacka M, Wiszniowka P, Vetulani J (1978) The distribution of apomorphine in rat brain: Possible behavioral correlates. Pol J Pharmacol 30:335–345
Neilson E, Lee T, Ellison G (1980a) Following several days of long-term administration d-amphetamine acquires hallucinogen-like properties. Psychopharmacology 68:197–200
Neilson E, Neilson M, Ellison G, Braestrup C (1980b) Decreased spiroperidol binding and LSD binding in rat brain after continuous amphetamine. Eur J Pharmacol 66:149–154
Roth RH, Waters J, Aghajanian GK (1973) Effect of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. Pergamon, Oxford, pp 567–574
Schwartz JC, Costentin J, Martres MP, Protais P, Baudry M (1978) Modulation of receptor mechanisms in the CNS: Hyperand hyposensitivity to catecholamines. Neuropharmacology 17:665–685
Smith RC, Tamminga C, Davis JM (1977a) Effect of apomorphine on schizophrenic symptoms. J Neural Transm 40:171–176
Smith RC, Tamminga C, Haraszti J, Paudey J, Davis JM (1977b) Effect of dopamine agonists in tardive dyskinesia. Am J Psychiatry 134:763–768
Tamminga CA, Schaffer MH, Smith RC, Davis JM (1978) Schizophrenic symptoms improve with apomorphine. Science 200:567–568
Trulson ME, Jacobs BL (1979) Long-term amphetamine treatment decreases brain serotonin metabolism: Implications for theories of schizophrenia. Science 205:1295–1297
Walters JR, Bunney BS, Roth RH (1975) Piribedil and apomorphine: Pre- and postsynaptic effects on dopamine synthesis and neuronal activity. Adv Neurol 9:273–284
Westerink BHC, Spaan SJ (1982) On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in rat brain. J Neurochem 38:680–686
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davis, R.E., Sant, W.W. & Ellison, G. Continuous low-level apomorphine administration induces motor abnormalities and hallucinogen-like behaviors. Psychopharmacology 85, 1–7 (1985). https://doi.org/10.1007/BF00427314
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427314